Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parallel Effects of Ketamine and Schizophrenia on Neurocognitive Function

NCT02675530 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02675530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02675530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parallel Effects of Ketamine and Schizophrenia on Neurocognitive Function
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2007
Completion date
December 31, 2011
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia